Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to suppression of hepatic de novo lipogenesis and significant improvements in MRI-PDFF, MRE, and markers of fibrosis after 12 weeks of therapy in patients with NASH
Lawitz, E.J., Poordad, F., Coste, A., Loo, N., Djedjos, C.S., McColgan, B., Jia, C., Xu, R., Myers, R.P., Subramanian, G.M., McHutchison, J.G., Middleton, M.S., Sirlin, C., Nyangau, E., Fitch, M., Li,Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)30328-8
File:
PDF, 68 KB
english, 2017